AG Fitch Urges Administration to Protect GLP-1 Drugs from Chinese Exploitation
(Jackson, Mississippi) — Ahead of Xi Jinping’s meeting with the President, Attorney General Lynn Fitch joined a 20-state letter to Secretary of State and National Security Advisor Marco Rubio urging the administration to guard against Chinese efforts to introduce low-quality and unsafe pharmaceutical ingredients to the U.S. pharmaceutical supply chain, given recent reports of Chinese-source businesses circumventing American safeguards.
“The FDA has set up a structure to protect American healthcare consumers from unsafe and ineffective overseas products, but some suppliers, particularly from China, are looking for ways around those safeguards. Constant vigilance is needed. I am proud to stand with my colleagues and offer our support to the administration to ensure consumers are purchasing safe, regulated products,” said Attorney General Lynn Fitch.
In September 2025, the Food and Drug Administration (FDA) authorized the creation of a “Green List” of suppliers to help stop potentially dangerous GLP-1 drugs and active pharmaceutical ingredients from unverified foreign sources from entering the U.S. market. The attorneys general identify risks from pharmaceutical ingredients used in popular compounded GLP-1 drugs, including semaglutide, tirzepatide, and retatrutide. Some reports indicate Chinese companies with direct ties to entities who manufacture fentanyl are now selling cosmetic and weight-loss peptides. The attorneys general also note the recent FDA warning letter to Chinese company Harbin Jixianglong Biotech Co., Ltd (Harbin) when it was found to have purchased knock-off semaglutide from a non-Green List facility. Since Harbin was on the Green List, it was only after an on-site inspection that it was discovered that Harbin had repackaged and relabeled the non-Green List products under Harbin’s name, changed the manufacturing and retest dates, and distributed to the United States.
Attorney General Fitch was one of two attorneys general to sue China for COVID-related damages. In November 2025, a federal district court ordered China to pay more than $25 billion, plus post-judgment interest and costs, to Mississippi in that suit.
Joining Attorney General Fitch in the letter to Secretary Rubio are the attorneys general of Alabama, Arkansas, Georgia, Idaho, Indiana, Iowa, Kansas, Kentucky, Louisiana, Missouri, Montana, Nebraska, North Dakota, Ohio, Oklahoma, South Carolina, Tennessee, Utah, and West Virginia.





